Scott Rudge

PhD, MS, Chemical Engineering, Purdue University,
BS, Chemical Engineering, Worcester Polytechnic Institute

Founder, Syner-G BioPharma Group, 2023; Sr. VP Product Development, Margaux Biologics, 2011; COO, RMC Pharmaceutical Solutions, 2003 (acquired by SynerG BioPharma (2023); Sr. VP Product Development, Bradmer Pharma, 2008-2009; President, Windom Peak Pharmaceuticals, 2005-2008; VP, Operations, FeRx Inc., 1997-2004; Sr. Scientific Investigator, Amylin Pharmaceuticals, 1994-1997; Process Engineer, Synergen, 1991-1994; Staff Scientist, NIST, 1989-1991.

Scholarly activities Adjunct Professor, Chemical Engineering, U. Colorado. Textbook: Bioseparation Science and Engineering. Perry’s Chemical Engineering Handbook Chapter in Biotechnology; Co-editor, CRC “Process Validation in Manufacturing of Biopharmaceuticals.” Reviewer: National Academy of Science ten-year strategic goals for separation sciences (2020).